Growth Metrics

Vertex Pharmaceuticals (VRTX) EPS (Weighted Average and Diluted) (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Revolution Medicines 32.39 Bn 32.39 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -13.36%
Dec 31, 2025 10.48%
Sep 30, 2025 5.26%
Jun 30, 2025 60.24%
Mar 31, 2025 -29.46%
Dec 31, 2024 -11.97%
Sep 30, 2024 128.81%
Jun 30, 2024 -430.64%
Mar 31, 2024 13.48%
Dec 31, 2023 -6.55%
Sep 30, 2023 12.78%
Jun 30, 2023 30.86%
Mar 31, 2023 -14.33%
Dec 31, 2022 -12.53%
Sep 30, 2022 14.70%
Jun 30, 2022 5.74%
Mar 31, 2022 -0.67%
Dec 31, 2021 -9.15%
Sep 30, 2021 1,161.54%
Jun 30, 2021 -89.56%
Mar 31, 2021 8.26%
Dec 31, 2020 -9.09%
Sep 30, 2020 -20.44%
Jun 30, 2020 38.86%
Mar 31, 2020 2.69%
Dec 31, 2019 913.64%
Sep 30, 2019 -78.64%
Jun 30, 2019 0.00%
Mar 31, 2019 -82.75%
Dec 31, 2018 1,094.00%
Sep 30, 2018 -37.50%
Jun 30, 2018 -1.23%
Mar 31, 2018 107.69%
Dec 31, 2017 195.12%
Sep 30, 2017 -685.71%
Jun 30, 2017 -92.93%
Mar 31, 2017 661.54%
Dec 31, 2016 181.25%
Sep 30, 2016 38.46%
Jun 30, 2016 -52.94%
Mar 31, 2016 45.16%
Dec 31, 2015 20.51%
Sep 30, 2015 50.00%
Jun 30, 2015 6.02%
Mar 31, 2015 -12.16%
Dec 31, 2014 -2.78%
Sep 30, 2014 -5.88%
Jun 30, 2014 32.00%
Mar 31, 2014 -626.32%
Dec 31, 2013 135.19%
Sep 30, 2013 -107.69%
Jun 30, 2013 81.82%
Mar 31, 2013 -308.57%
Dec 31, 2012 -29.63%
Sep 30, 2012 12.90%
Jun 30, 2012 -172.09%
Mar 31, 2012 -41.89%
Dec 31, 2011 -27.45%
Mar 31, 2011 3.33%
Dec 31, 2010 13.46%
Sep 30, 2010 -4.00%
Jun 30, 2010 -20.48%
Mar 31, 2010 3.49%
Dec 31, 2009 -2.38%
Sep 30, 2009 15.15%
Jun 30, 2009 4.81%